The analysis of murine and human gastric tumor organoids uncovered an association between RTK/MAPK pathway activity and susceptibility to HDAC inhibition, thereby identifying a potential new treatment approach for gastric cancer patients. This evidence concerns the gene HDAC9 and gastric cancer.